NCT05952219View on ClinicalTrials.gov

Study to Evaluate the Safety and Pharmacokinetics of CKD-379

PHASE1UnknownINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 2, 2023

Primary Completion Date

June 19, 2023

Study Completion Date

October 30, 2023

Conditions
Type II Diabetes Mellitus
Interventions
DRUG

CKD-379

2 tablet administration under fed condition

DRUG

D759+D745+D029+D150

4 tablet co-administration under fed condition

Trial Locations (1)

Unknown

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY